Cytokines, like tumor necrosis factor (TNF), modulate tissue injury in experimental stroke and affect infarct evolution, making them good targets for potential future stroke therapy (Lam Be Rtsen et al., 2012). This evidence concerns the gene TNF and stroke disorder.